期刊文献+

载脂蛋白C3启动子区基因多态性与非酒精性脂肪性肝病的相关性 被引量:5

Association between APOC3 promoter region polymorphisms and non-alcohofic fatty fiver disease
原文传递
导出
摘要 目的探讨载脂蛋白(APO)C3基因启动子区两位点多态性T-455C、C-482T与非酒精性脂肪性肝病(NAFLD)遗传易感性的相关性。方法对287例NAFLD患者和310名正常对照采用多聚酶链反应(PCR)及基因型检测方法对两变异位点进行基因型检测。随机选取180人采用酶联免疫吸附试验(ELISA)测定APOC3的含量。并比较各组基因型频率、等位基因频率及临床资料。根据数据资料的不同,分别行PearsonX。检验、logistic回归分析、t检验、χ^2检验或行线性回归分析。结果-455、-482位点基因型及等位基因在NAFLD组与对照组中的分布频率差异无统计学意义(P〉0.05)。相对于野生型-455TT或-482CC,含突变位点基因型未增加NAFLD的发病风险,经多变量logistic回归分析校正混杂因素后,含等位基因-455C、-482T的基因型携带者发生NAFLD的比值比(OR及95%CI)分别为1.25(0.79~1.96)及1.20(0.76~1.89),P〉0.05。临床资料及各生物化学指标在野生型组及含突变位点组中均未见明显差异(P〉0.05)。结论在汉族人群中,APOC3基因启动子区两位点多态性与NAFLD的发生无明显相关性。 Objeelive To investigate the association between two polymorphisms of the APOC3 gene (T-455C and C-482T) and hereditary risk of non-alcoholic fatty liver disease (NAFLD). Methods A total of 287 patients with NAFLD and 310 control subjects were genotyped by PCR and direct sequencing. Serum lipid profiles were also detected by standard biochemical methods. One-hundred-and-eighty of the study participants were used to measure the APOC3 content by enzyme-linked immunosorbent assay. Inter-group differences and associations were assessed statistically using Chi square and t tests and logistic and linear regression analyses. Results The frequencies of neither the genotypes or alleles were significantly different between the NAFLD cases and the controls. Compared with the most common genotypes -455TT or -482CC, none of the variants showed a significant increase in risk of NAFLD or for the clinical and biochemical parameters. The adjusted odds ratios (with 95% confidence intervals) of NAFLD were 1.25 (0.79 - 1.96) and 1.20 (0.76 - 1.89) for carriers of the APOC3 -455C and -482 T variants respectively (P 〉 0.05). Conclusion The T-455C and C-482T polymorphisms of the APOC3 gene are not associated with risk of NAFLD, pathogenic changes in lipid profiles, or insulin resistance in Han Chinese.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2014年第5期374-379,共6页 Chinese Journal of Hepatology
基金 国家自然科学基金(81170337/H0304)
关键词 脂肪肝 非酒精性 单核苷酸多态性 载脂蛋白C3 Fatty liver, nonalcoholic Single neucleotide polymorphism Apolipoprotein C3
  • 相关文献

参考文献15

  • 1Miller M, Rhyne J, Chert H, et al. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome[J]. Arch Med Res, 2007, 38: 444-451.
  • 2Abd-EI-Aziz TA, Mohamed RH, El-Shal AS. Synergistic effect between lipoprotein lipase and apolipoprotein C3 genes in determining the severity of coronary artery disease[J]. J Cardiovasc Transl Res, 2013, 6: 430-435.
  • 3中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):43-48. 被引量:470
  • 4Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol, 2009, 50: 204-210.
  • 5Valenti L, A1-Serri A, Daly AK, et al. Homozygosity for the patatin- like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease[J]. Hepatology, 2010, 51: 1209-1217.
  • 6Krawczyk M, Griinhage F, Zimmer V, et al. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease[J]. I Hepatol, 2011, 55: 299-306.
  • 7Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease[J]. N Engl J Mcd, 2010, 362: 1082-1089.
  • 8Sentinelli F, Romeo S, Maglio C, et al. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans[J]. Lipids Health Dis, 2011, 10: 93.
  • 9Ooi EM, Barrett PH, Chan DC, et al. Apolipoprotein C-Ⅲ: understanding an emerging cardiovascular risk factor[J]. Clin Sci (Lond), 2008, 114: 611-624.
  • 10Zheng C, Khoo C, Furtado J, et al. Apolipoprotein C-Ⅲ and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype[J]. Circulation, 2010, 121: 1722-1734.

二级参考文献3

共引文献469

同被引文献57

引证文献5

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部